SEC Form 4 · accession 0001127602-15-012345
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank Haluska
Officer — SVP, Clinical R&D, CMO
Period of report
Mar 19, 2015
Accepted (ET)
Mar 23, 2015 · 5:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 19, 2015 | M | 6,500 | $0.00 | A | 114,999 | D | |
| Common StockF2 | Mar 20, 2015 | S | 3,575 | $8.8488 | D | 111,424 | D | |
| Common Stock | Mar 20, 2015 | M | 6,000 | $0.00 | A | 117,424 | D | |
| Common StockF2 | Mar 23, 2015 | S | 3,300 | $8.5541 | D | 114,124 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF4,F5 | — | Mar 19, 2015 | M | 6,500 | D | — | — | Common Stock | 6,500 | 6,500 | D |
| Restricted Stock UnitsF4,F6 | — | Mar 20, 2015 | M | 6,000 | D | — | — | Common Stock | 6,000 | 0 | D |
Explanation of responses
- F1Shares were acquired upon vesting of restricted stock units awarded on March 19, 2013.
- F2Represents shares sold to satisfy withholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
- F3Shares were acquired upon vesting of restricted stock units awarded on March 20, 2012.
- F4Each restricted stock unit represents a right to receive one share of ARIAD common stock.
- F5Restricted Stock Units vest as to 33-1/3% of the award on each of March 19, 2014, March 19, 2015 and March 19, 2016
- F6Restricted Stock Units vest as to 33-1/3% of the award on March 20, 2013, March 20, 2014 and March 20, 2015.